Participating Partners



Abbott South Africa is a subsidiary of the US-based parent company, and has had a proud presence in South Africa for 75 years.

Abbott’s businesses are varied, offering both state-of-the-art technologies and solutions across the continuum of care – addressing the world’s most pressing health needs.

The products range from Branded Generics, Nutritional Products and Diagnostic Systems and tests through pharmaceutical therapies and Medical Devices, which help build more productive communities.

Abbott serves people in more than 150 countries and currently sells and distributes over 120 pharmaceutical products across 15 countries in Africa.




At Abbvie, we have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in healthcare today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe. When it comes to innovating, Abbvie starts with the patient. We draw on our deep expertise in some of the most difficult-to-treat diseases and on our understanding of the patient journey to identify opportunities to create better outcomes at every stage. This patient-centered approach to discovery and development ensures we remain focused on our goal of improving lives.




South African-based Aspen is the world’s 5th largest generic manufacturer by value and is included in the top 40 index of the Johannesburg Securities Exchange Ltd (JSE). It was recently ranked by Forbes as the world’s 10th most innovative company and by the Boston Consulting Group as a top 100 Boston challenger. It is South Africa’s number 1 pharmaceutical company in both the public and private sectors and is a major supplier of branded and generic pharmaceuticals into 150 markets globally. One in four products dispensed in South Africa and 1 in 5 prescribed in Australia is for an Aspen product, endorsing Aspen products’ quality, efficacy and affordability.

In Africa, Aspen is the largest pharmaceutical manufacturer and its brand has become synonymous with quality generics, resulting in more people asking for Aspen generics than any other brand. Today Aspen employs over 10 000 people on all 6 continents and approximately half of those reside in South Africa, which is the manufacturing hub for most of its South African and global manufacture. In total Aspen has 20 manufacturing facilities in South Africa and other parts of the world.



Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to or



Clinix Health Group was established in 1992 and offers private healthcare services and products in South Africa. It now owns and manages eight private hospitals, two occupational health clinics and has approximately 2 600 individuals that are working in its hospitals on a daily basis. The Group’s hospitals offer comprehensive services which include, but are not limited to, primary, secondary and tertiary healthcare, emergency care, specialist services, diagnostic testing, physiotherapy, radiology and pathology.




Clicks is independently rated as South Africa’s leading health and beauty retailer with the largest retail pharmacy footprint in the country. Clicks has 339 in-store dispensaries and 150 in-store clinics in its network of 464 stores across Southern Africa. The Clicks retail offering is complemented by a national direct-to-patient courier pharmacy service, Clicks Direct Medicines, and nursing practitioner-led primary healthcare services in-store. This allows Clicks to provide South Africa’s largest and most accessible fully integrated primary healthcare offering to patients.


Clinix Health Group was established in 1992 and offers private healthcare services and products in South Africa. It now owns and manages eight private hospitals, two occupational health clinics and has approximately 2 600 individuals that are working in its hospitals on a daily basis. The Group’s hospitals offer comprehensive services which include, but are not limited to, primary, secondary and tertiary healthcare, emergency care, specialist services, diagnostic testing, physiotherapy, radiology and pathology.



Discovery is an integrated financial services organisation, serving clients in four continents. Discovery operates in the following markets locally and internationally:

  • The private healthcare market in South Africa, the United Kingdom and China
  • The life assurance market in South Africa, the United Kingdom and Singapore
  • The long-term savings and investment market in South Africa
  • The short-term insurance market in South Africa

Core to Discovery’s differentiated business model is the underpinning of health and life insurance with Vitality, Discovery’s wellness programme. The global Vitality membership base now exceeds five million lives.






Dis-Chem is a growing retail chain of over 70 pharmacies, located throughout South Africa and often referred to as ‘mega-pharmacies’ because of their size. They carry a wide range of front shop items normally found in pharmacies and specialised items such as surgical equipment and orthopaedic shoes. Dis-Chem is a dominant player in prescriptions, over-the-counter (OTC) medications and health support, including food. Dis-Chem has made its mark on service, selection and competitive pricing.




Galderma is an international pharmaceutical company specialising exclusively in the research, development and marketing of therapeutic, corrective and aesthetic solutions for dermatology patients. Galderma (a joint venture between Nestlé and L’Oréal) is a leading player in the worldwide dermatology market. Galderma South Africa opened in 1996 and has established itself as a local leader in dermatology. It is an innovation-based company focused on meeting the needs of dermatology patients and physicians.


Imperial Health Sciences




IMPERIAL is Africa’s leading partner in the healthcare supply chain, driving to ensure the secure and sustainable supply of affordable, quality medicines to the people of our continent.

We have distribution and wholesale operations in South Africa, Botswana, Kenya, Mozambique, Ghana, Nigeria, Malawi and the Netherlands with downstream distribution partners providing reach into 26 countries. Our supply chain partnerships with the Global fund and USAID and numerous Ministries of Health enhance access for public health programmes, while our commercial operations support the emerging private markets of Africa.

IMPERIAL’s five pillars of excellence are: our IT and quality management systems, our dedicated and skilled people, our world-class capacity and our innovative business solutions. These, with our values of Respect, Execution, Appreciation and Pride underpin our culture and our ability to deliver.




iNova Pharmaceuticals and Bausch & Lomb are part of the Valeant Pharmaceuticals International group of companies. Our aim is to make everyday life better for all our customers and consumers by providing quality, high-end products that meet individual needs. iNova develops and markets a range of professionally endorsed healthcare products to South Africa and other selected African countries. The products are predominantly well-known best sellers in the areas of cough, oral health and sore throat, appetite control, dermatology and women’s health, as well as certain areas of pain. Bausch & Lomb is one of the best-known healthcare brands in the world, offering the widest range of eye health products including contact lenses and lens care products, pharmaceuticals, intraocular lenses and other eye surgery products. Over the past 150 years, Bausch & Lomb has become a global hallmark for innovation and quality.




Janssen Pharmaceutical Companies of Johnson & Johnson focuses on the following five therapeutic areas:

  • Cardiovascular and Metabolism
  • Immunology
  • Infectious Diseases and Vaccines
  • Neuroscience
  • Oncology

It comprises companies with nearly 40 000 employees in more than 150 countries around the world and works within and beyond communities globally to bring innovative treatments for serious unmet medical needs. Providing information, education and support to access the treatments patients need and use for the best possible results is key to the company’s success. Janssen collaborates with the world for the health of everyone in it by combining its expertise and capabilities of others, seeking the most creative minds in every field in order to solve problems and find transformational solutions. This commitment to collaboration in research and education and patient access ensures that new ideas turn into medical solutions for patients in need.




Joint Medical Holdings is a Private Hospital Group established 30 years ago. Our hospitals have a total of 530 beds: City, Ascot Park, Durdoc and Isipingo. We accommodate patients from the surrounding areas and as far as Kokstad and the Eastern Cape. The Group also offers emergency medical transport by Citi-Med Ambulance Services and has its own training school (Gandhi Mandela Nursing Academy). The Academy is well known for producing quality Enrolled Nurses and Enrolled Nursing Assistants. Accreditation has now been received to train Registered Nurses. JMH has been involved in a number of deserving CSR Projects, the most rewarding being the Cataract Operations Project providing free cataract  surgery to approximately 1 200 patients from the Provincial Hospitals’ waiting  list since 2007.


logo (1)

The Life Healthcare Group is a key role-player in the South African healthcare sector and is listed on the Johannesburg Stock Exchange (JSE). Our primary business is private acute hospital care. With 61 healthcare facilities, our group has one of the most extensive footprints in southern Africa. Life Healthcare is the first hospital group to have achieved ISO 9001 certification. We are dedicated to: LIFE – well-being and quality of life; HEALTH – clinical excellence in world class facilities; and CARE – quality service, respect and empathy for those entrusted to our care.

The Life Healthcare Group’s diversified business comprises three divisions:

  • Hospital division: comprising the core acute care hospital business and services for acute physical rehabilitation, acute mental healthcare and renal dialysis
  • Healthcare services division: comprising acute and long-term hospitalisation services to public sector patients provided by Life Esidimeni, as well as contracted occupational healthcare provided by Life Occupational Health to private and public employers
  • International division: comprising the Group’s investment in Max Healthcare, an acute care hospital business in India and Scanmed Multimedis, a leading private healthcare provider in Poland




Litha Healthcare Group Limited is a diversified healthcare group providing services, products and solutions to the public and private hospitals, pharmacies, general and allied practitioners, as well as government healthcare programmes in South Africa. LHG employs over 500 employees and is currently the only truly diversified healthcare company listed on the Johannesburg Stock Exchange (JSE). LHG’s business is divided into the following areas of healthcare specialisation:

  • Litha Biotech: manufacturing and distribution of human vaccines
  • Litha Medical: distribution of devices, consumables and equipment
  • Litha Pharma: distribution of generic, originator and complementary medicines

Its leadership team brings together a group of highly respected professionals with many years of experience within the South African healthcare sector.


Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia with a focus on providing acute care, specialist-orientated, multi-disciplinary hospital services and related service offerings.

Mediclinic Southern Africa is a wholly owned subsidiary of the South Africa-based international private healthcare group Mediclinic International, founded in 1983 and listed on the JSE, which has three operating divisions – Mediclinic Southern Africa which operates 52 private hospitals in South Africa and Namibia, Hirslanden which operates 16 private hospitals in Switzerland and Mediclinic Middle East which operates 2 private hospitals and 9 clinics in the United Arab Emirates.


medscheme_1 copy


Medscheme’s vision – ‘Creating a world of Sustainable Healthcare’- focuses on achieving sustainability through effective health risk management complemented by careful management of healthcare costs and a drive for operational efficiency. Medscheme is the largest health risk management services provider and second largest medical scheme administrator in South Africa. It offers innovative, integrated medical scheme administration and health risk management solutions. Medscheme covers the lives of over three million people through a network of branches located throughout South Africa, Africa and Mauritius.





With a track record of more than 23 years, the independently owned Mediscor PBM has become a leading managed care organisation in Southern Africa. Mediscor specialises in the electronic management of dispensed medicines irrespective of whether they are funded through public or private health insurance. All 2 900 pharmacies and most doctors in South Africa, Namibia, Swaziland and Lesotho submit their electronic claims via Mediscor. We currently manage the medicine benefits of some 1,6 million beneficiaries on behalf of 30 medical schemes and five insurance funds, 4 primary care provider groups and 4 sick benefit societies.



Netcare operates the largest private hospital, primary care and medical emergency service networks in South Africa (SA) as well as the biggest private dialysis service through a joint venture.
Netcare’s national footprint in SA comprises the following:

  • 50 private hospitals with 9 019 beds
  • Four public private partnership (PPP) hospitals: Universitas Private Hospital, Pelonomi Private Hospital, Settlers Hospital and Port Alfred Hospital, with 277 beds
  • 89 Medicross family medical and dental centres and Prime Cure clinics offering primary healthcare
  • Netcare 911 emergency medical services, with some six million managed lives
  • Retail and hospital pharmacy services offered through 83 Netcare pharmacies
  • 58 renal dialysis units through National Renal Care

In addition, Netcare manages a PPP in Lesotho that includes a 425-bed hospital in Maseru and four primary healthcare clinics.

Through the General Healthcare Group, Netcare is also the largest provider of acute hospital care in the United Kingdom (UK) with a network of 58 hospitals and a total of 2 896 beds.


novo nordisk

Novo Nordisk® is a global healthcare company and a world leader in diabetes care. In addition, Novo Nordisk® has a leading position within other areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. With headquarters in Denmark, Novo Nordisk® employs approximately 33 300 people in 75 countries and markets its products in 190 countries. The South African affiliate was established in 1959 and is a leader in diabetes care in the country.



Pfizer Inc.: Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.




UPD is South Africa’s leading full-range pharmaceutical wholesaler and distributor and the only wholesaler with a national presence. We are committed to leveraging our expertise in supply chain to help increase the efficiency of healthcare within South Africa. UPD supplies over 14 000 products to 3 000 customers per month, including every Clicks and Link pharmacy, all major private hospital groups and 1 400 independent pharmacies. Our scale and capability within the pharmaceutical supply chain is demonstrated through our ability to process over 8 000 orders per day and travel 150 000 kilometres per week to reach our entire customer base. UPD services the SADC region through our operation in Botswana.




Roche has been in existence for a 110 years. As the world’s largest biopharmaceutical company and supplier of in vitro diagnostics, Roche has brought many highly effective drugs to market, including the industry’s leading portfolio of cancer medicines while developing new diagnostic tools to support healthcare professionals and patients in managing diseases.

Roche focuses on developing medicines and diagnostics that will help patients live longer, better lives through finding innovative solutions for unmet medical needs. The company has operated in South Africa since 1947.

In 2014 Roche proudly celebrated 20 years as leading partner of the Transnet Phelophepa Healthcare Train, bringing over 5,8 million rural South African’s primary healthcare services.




Established in 1972, Servier Laboratories South Africa is a subsidiary of the leading French independent pharmaceutical company, Les Laboratoires Servier. Servier operates in 140 countries and 86% of Servier’s sales are achieved internationally, with an annual turnover of 3,9 billion. Servier Laboratories South Africa employs 100 employees. The Company’s major focus is on sales and marketing, however the subsidiary also has its own research unit. Servier is a research-based organisation focusing on the following therapeutic areas: Cardiovascular Disease, Metabolic Disease, Diseases of the Central Nervous System, Oncology and Rheumatology.


Advertising Partner



Ogilvy Healthworld is the specialist medical and pharmaceutical division of the global Ogilvy & Mather group. Ogilvy Healthworld South Africa is a team of medical professionals, marketing experts and creative gurus that live for the challenge of medical and pharmaceutical marketing. Our in-depth market knowledge ensures quick turnaround and accurate and brilliantly creative work, while a powerful global network gives our clients access to global integration, knowledge sharing and worldwide market insights and trends.

We are a through-the-line agency ideally positioned to offer the right balance of medical science, consumer insight and creativity to enhance brands and give a measurable Return On Investment. Our expertise is demonstrated through our ability to identify the appropriate connection points, communication channels and tactics to support the communication strategy and, above all, a thorough understanding of the legislation and challenges that face the medical and pharmaceutical industry.

Our partnership with PHEF is pro-bono and reflects our vision of local knowledge with global insights to uplift and empower all the people of our Rainbow Nation.